Access the full text.
Sign up today, get DeepDyve free for 14 days.
K. Denzer, M. Kleijmeer, H. Heijnen, W. Stoorvogel, H. Geuze (2000)
Exosome: from internal vesicle of the multivesicular body to intercellular signaling device.Journal of cell science, 113 Pt 19
Xin Yu, S. Harris, A. Levine (2006)
The regulation of exosome secretion: a novel function of the p53 protein.Cancer research, 66 9
Rainy Mears, R. Craven, Sarah Hanrahan, N. Totty, Carol Upton, S. Young, P. Patel, P. Selby, R. Banks (2004)
Proteomic analysis of melanoma‐derived exosomes by two‐dimensional polyacrylamide gel electrophoresis and mass spectrometryPROTEOMICS, 4
L. Zitvogel, A. Régnault, A. Lozier, J. Wolfers, C. Flament, D. Tenza, P. Ricciardi-Castagnoli, G. Raposo, S. Amigorena (1998)
Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell derived exosomesNature Medicine, 4
M. Iero, R. Valenti, V. Huber, P. Filipazzi, G. Parmiani, S. Fais, L. Rivoltini (2008)
Tumour-released exosomes and their implications in cancer immunityCell Death and Differentiation, 15
T. Mercer, M. Dinger, C. Bracken, G. Kolle, Jan Szubert, D. Korbie, Marjan Askarian-Amiri, B. Gardiner, G. Goodall, S. Grimmond, J. Mattick (2010)
Regulated post-transcriptional RNA cleavage diversifies the eukaryotic transcriptome.Genome research, 20 12
D. Altieri (2010)
Survivin and IAP proteins in cell-death mechanisms.The Biochemical journal, 430 2
Salma Khan, Jonathan Aspe, M. Asumen, Frankis Almaguel, Oludare Odumosu, S. Acevedo-Martinez, M. León, W. Langridge, N. Wall (2009)
Extracellular, cell-permeable survivin inhibits apoptosis while promoting proliferative and metastatic potentialBritish Journal of Cancer, 100
Mark Verdecia, Han-kuei Huang, E. Dutil, D. Kaiser, T. Hunter, J. Noel (2000)
Structure of the human anti-apoptotic protein survivin reveals a dimeric arrangementNature Structural Biology, 7
Mark Verdecia, M. Bowman, K. Lu, T. Hunter, J. Noel (2000)
Structural basis for phosphoserine-proline recognition by group IV WW domainsNature Structural Biology, 7
H. Anderson, D. Mulhall, Rama Garimella (2010)
Role of extracellular membrane vesicles in the pathogenesis of various diseases, including cancer, renal diseases, atherosclerosis, and arthritisLaboratory Investigation, 90
J. Skog, T. Wurdinger, Sjoerd Rijn, D. Meijer, Laura Gainche, M. Sena-Esteves, W. Curry, R. Carter, Anna Krichevsky, X. Breakefield (2008)
Glioblastoma microvesicles transport RNA and protein that promote tumor growth and provide diagnostic biomarkersNature cell biology, 10
(2008)
Survivin: key regulators of mitosis and apoptosis and novel targets for cancer therapeutics
Guillaume Niel, I. Porto-Carreiro, Sabrina Simoes, G. Raposo (2006)
Exosomes: a common pathway for a specialized function.Journal of biochemistry, 140 1
R. Safaei, Barrett Larson, Timothy Cheng, Michael Gibson, S. Otani, W. Naerdemann, S. Howell (2005)
Abnormal lysosomal trafficking and enhanced exosomal export of cisplatin in drug-resistant human ovarian carcinoma cellsMolecular Cancer Therapeutics, 4
(2012)
IAPs : guardians of RIPK 1
Q. Deveraux, R. Takahashi, G. Salvesen, John Reed (1997)
X-linked IAP is a direct inhibitor of cell-death proteasesNature, 388
R. Nieuwland, A. Sturk (2010)
Why do cells release vesicles?Thrombosis research, 125 Suppl 1
Hamid Cheshmi (2011)
Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkersNew Cellular and Molecular Biotechnology Journal, 1
R. Valenti, V. Huber, M. Iero, P. Filipazzi, G. Parmiani, L. Rivoltini (2007)
Tumor-released microvesicles as vehicles of immunosuppression.Cancer research, 67 7
D. Taylor, Ç. Gerçel-Taylor (2005)
Tumour-derived exosomes and their role in cancer-associated T-cell signalling defectsBritish Journal of Cancer, 92
A. Mita, M. Mita, S. Nawrocki, F. Giles (2008)
Survivin: Key Regulator of Mitosis and Apoptosis and Novel Target for Cancer TherapeuticsClinical Cancer Research, 14
D. Altieri (2008)
Survivin, cancer networks and pathway-directed drug discoveryNature Reviews Cancer, 8
D. Altieri (2003)
Validating survivin as a cancer therapeutic targetNature Reviews Cancer, 3
R. Simpson, Justin Lim, R. Moritz, S. Mathivanan (2009)
Exosomes: proteomic insights and diagnostic potentialExpert Review of Proteomics, 6
M. Valenzuela, Imilce Castro, Amber Gonda, Carlos Osterman, J. Jutzy, Jonathan Aspe, Salma Khan, J. Neidigh, N. Wall (2015)
Cell death in response to antimetabolites directed at ribonucleotide reductase and thymidylate synthaseOncoTargets and therapy, 8
E. Wieckowski, T. Whiteside (2006)
Human tumor-derived vs dendritic cell-derived exosomes have distinct biologic roles and molecular profilesImmunologic Research, 36
Fengzhi Li (2003)
Survivin study: What is the next wave?Journal of Cellular Physiology, 197
K. Shedden, Xuesun Xie, Parthapratim Chandaroy, Young‐Tae Chang, G. Rosania (2003)
Expulsion of small molecules in vesicles shed by cancer cells: association with gene expression and chemosensitivity profiles.Cancer research, 63 15
Sascha Keller, M. Sanderson, Alexander Stoeck, P. Altevogt (2006)
Exosomes: from biogenesis and secretion to biological function.Immunology letters, 107 2
V. Huber, S. Fais, M. Iero, L. Lugini, P. Canese, P. Squarcina, Annamaria Zaccheddu, M. Colone, G. Arancia, M. Gentile, E. Seregni, R. Valenti, G. Ballabio, F. Belli, E. Leo, G. Parmiani, L. Rivoltini (2005)
Human colorectal cancer cells induce T-cell death through release of proapoptotic microvesicles: role in immune escape.Gastroenterology, 128 7
J. Hegmans, M. Bard, A. Hemmes, T. Luider, M. Kleijmeer, J. Prins, L. Zitvogel, S. Burgers, H. Hoogsteden, B. Lambrecht (2004)
Proteomic analysis of exosomes secreted by human mesothelioma cells.The American journal of pathology, 164 5
C. Théry, M. Ostrowski, É. Segura (2009)
Membrane vesicles as conveyors of immune responsesNature Reviews Immunology, 9
J. Jutzy, Salma Khan, Malyn Asuncion-Valenzuela, Terry-Ann Milford, K. Payne, N. Wall (2013)
Tumor-Released Survivin Induces a Type-2 T Cell Response and Decreases Cytotoxic T Cell Function, in VitroCancer Microenvironment, 6
F. André, N. Schartz, M. Movassagh, C. Flament, P. Pautier, P. Morice, C. Pomel, C. Lhommé, B. Escudier, T. Chevalier, T. Tursz, S. Amigorena, G. Raposo, E. Angevin, L. Zitvogel (2002)
Malignant effusions and immunogenic tumour-derived exosomesThe Lancet, 360
(2008)
Senescenceassociated exosome release from human prostate cancer cells
L. Miller (1999)
An exegesis of IAPs: salvation and surprises from BIR motifs.Trends in cell biology, 9 8
N. Roy, Q. Deveraux, R. Takahashi, G. Salvesen, John Reed (1997)
The c‐IAP‐1 and c‐IAP‐2 proteins are direct inhibitors of specific caspasesThe EMBO Journal, 16
G. Ambrosini, C. Adida, D. Altieri (1997)
A novel anti-apoptosis gene, survivin, expressed in cancer and lymphomaNature Medicine, 3
Q. Deveraux, John Reed (1999)
IAP family proteins--suppressors of apoptosis.Genes & development, 13 3
Existence of Exosomal IAPs
AO Batagov, IV Kurochkin (2013)
Exosomes secreted by human cells transport largely mRNA fragments that are enriched in the 3′-untranslated regionsBiol Direct, 8
M. Darding, Pascal Meier (2011)
IAPs: Guardians of RIPK1Cell Death and Differentiation, 19
J. Wolfers, A. Lozier, G. Raposo, A. Régnault, C. Théry, C. Masurier, C. Flament, S. Pouzieux, F. Faure, T. Tursz, E. Angevin, S. Amigorena, L. Zitvogel (2001)
Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-primingNature Medicine, 7
A. Ginestra, M. Placa, F. Saladino, D. Cassarà, H. Nagase, M. Vittorelli (1998)
The amount and proteolytic content of vesicles shed by human cancer cell lines correlates with their in vitro invasiveness.Anticancer research, 18 5A
M. Bard, J. Hegmans, A. Hemmes, T. Luider, R. Willemsen, L. Severijnen, J. Meerbeeck, S. Burgers, H. Hoogsteden, B. Lambrecht (2004)
Proteomic analysis of exosomes isolated from human malignant pleural effusions.American journal of respiratory cell and molecular biology, 31 1
K. Al-Nedawi, B. Meehan, R. Kerbel, A. Allison, J. Rak (2009)
Endothelial expression of autocrine VEGF upon the uptake of tumor-derived microvesicles containing oncogenic EGFRProceedings of the National Academy of Sciences, 106
Salma Khan, Jessica Jutzy, Jonathan Aspe, Dalmor McGregor, J. Neidigh, N. Wall (2010)
Survivin is released from cancer cells via exosomesApoptosis, 16
B. Lehmann, M. Paine, A. Brooks, J. McCubrey, R. Renegar, Rong Wang, D. Terrian (2008)
Senescence-associated exosome release from human prostate cancer cells.Cancer research, 68 19
Juan Ugalde, S. Podell, P. Narasingarao, E. Allen (2011)
Xenorhodopsins, an enigmatic new class of microbial rhodopsins horizontally transferred between archaea and bacteriaBiology Direct, 6
A. Janowska-Wieczorek, M. Wysoczynski, J. Kijowski, L. Marquez-Curtis, B. Machalinski, J. Ratajczak, M. Ratajczak (2005)
Microvesicles derived from activated platelets induce metastasis and angiogenesis in lung cancerInternational Journal of Cancer, 113
F. Mbeunkui, D. Johann (2009)
Cancer and the tumor microenvironment: a review of an essential relationshipCancer Chemotherapy and Pharmacology, 63
(2012)
IAPs: guardians of RIPK1. Cell Death Differ
Exosomes are endosomal-derived nanovesicles released by normal and tumor cells which have been shown to transfer functionally active protein, lipids, mRNAs and miRNAs between cells. Varying in molecular profiles, biological roles, functional roles and protein contents, exosomes have been described as “multi-purpose carriers” playing a role in supporting the survival and growth of tumor cells. The IAP Survivin has been found to be present in tumor exosomes. However, the existence of other IAPs in tumor exosomes is still unknown. Survivin, cIAP1, cIAP2 and XIAP mRNA and protein are differently expressed in a panel of tumor cell lines: DLCL2, HeLa, MCF-7, Panc-1, and PC3. Exosomes were isolated from conditioned media collected from the cells from which RNA and protein were extracted. Our results provide evidence that like Survivin, XIAP, cIAP1 and cIAP2 proteins are found in tumor exosomes. The mRNA expression, however, is differentially expressed across the tumor cell lines. The presence of these bioactive molecules in exosomes may not only serve as warning signals, but also play a role in providing protection to the cancer cells against changes that are constantly occurring in the tumor microenvironment.
Cancer Microenvironment – Springer Journals
Published: May 16, 2015
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.